Abstract
Objective: This study presents a novel computational approach for analyzing electroencephalogram (EEG) signals, focusing on the distribution and variability of energy in different frequency bands. The proposed method, FFT Weed Plot, systematically encodes EEG spectral information into structured metrics that facilitate quantitative analysis. Methods: The methodology employs Fast Fourier Transform (FFT) to compute the Power Spectral Density (PSD) of EEG signals. A novel encoding technique transforms frequency band distributions into six-entry vectors,referred to as "words," which serve as the basis for three key metrics: a scalar value ϕ, a vector ω , and a matrix H. These metrics are evaluated using a dataset comprising EEG recordings from 30 healthy individuals and 15 patients with epilepsy. Machine learning classifiers are then applied to assess the discriminatory power of the proposed features. Results: The classification models achieved a 95.55% accuracy, 93.33% sensitivity, and 96.67% specificity, demonstrating the robustness of the proposed metrics in distinguishing between control and epileptic EEGs. Conclusions: The FFT Weed Plot method provides a novel approach for EEG signal quantification, improving the systematization of spectral analysis in neurophysiological studies. The metrics developed could serve as quantitative descriptors for automated EEG interpretation, offering potential applications in clinical and research settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding:This research received no external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The research protocol was approved by the ethics committee of Hospital Cordoba, Cordoba, Argentina and registered in the Ministry of Health of the Cordoba Province on 20-03-2017 under number 3170. (protocol code CO000152 and 20-03-2017).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.